Clinical trial INCB 99318-122
A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Select Advanced Solid Tumors (INCB99318-122)
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| EudraCT Identifier | 2019-004990-21 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04272034 |
| Last update |